AstraZeneca Pharma India

This treatment can enhance hyperkalaemia management in adults, a condition characterised by elevated potassium levels that often…

Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…

Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer

This drug is used for the treatment of critical bleeding conditions associated with use of novel anticoagulants (Factor Xa…

The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…

Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma…

Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period…

The notice of demand alleges that the company has overcharged about Rs 157.38 crore from March 8, 2019 to January 31, 2021, for…

Consequently, AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016,…

It is now approved as monotherapy for adjuvant treatment after complete tumour resection in patients with NSCLC